ZebraTox

ZebraTox is at the forefront of biotechnology research, dedicated to transforming the gold standard of pre-clinical drug testing. With a focus on innovation and efficiency, ZebraTox is revolutionizing the way new therapeutics are evaluated for safety and efficacy.

ZebraTox is committed to streamlining the drug development pipeline through its novel, high-throughput toxicity screening platform utilizing zebrafish. Their patent-pending genotoxicity assay bridges the gap between cost-effective in vitro toxicity studies and the translatability of live vertebrate studies. This unique approach accelerates the identification of potential issues early in the development process, saving time and resources.

ZebraTox's overarching goal is to reduce the risk of late-stage failures and accelerate the path to potentially life-saving therapeutics by making toxicity screening faster and more affordable than existing methods. We invite the management of ZebraTox to create a customized and exclusive company showcase and product listing on our platform, highlighting their groundbreaking work in biotechnology research.